K252681: EnCor EnCompass™ Breast Biopsy and Tissue Removal System (FDA 510(k) & Recall Dossier)

U.S. FDA 510(k) Premarket Notification K252681 (EnCor EnCompass™ Breast Biopsy and Tissue Removal System, cleared 2025-12-12 for Bard Peripheral Vascular, Inc.) reconciled with CDRH recall records on Predicate Ledger.

Reconciled U.S. FDA 510(k) Premarket Notification Metadata for K252681
Regulatory FieldVerified FDA Record
FDA 510(k) NumberK252681
Cleared Device Trade / Generic NameEnCor EnCompass™ Breast Biopsy and Tissue Removal System
FDA Applicant on FilingBard Peripheral Vascular, Inc.
FDA 3-Letter Product ClassificationProduct Code KNW
FDA Substantial Equivalence Decision Date2025-12-12
De-Broadcasted Recall LinkageLinked to at least one historical or open CDRH/openFDA recall notice (1976 to 2026)

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for Becton, Dickinson and Company (BD) across sibling Meru public-data platforms.

Inspect consolidated manufacturer lineage at Bard Peripheral Vascular, Inc., compare peer devices under FDA Product Code KNW, or browse all 20 FDA clinical specialties.

Meru AI Healthcare Data Engineering: Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI → · AI for Healthcare Practice · Healthcare Price & Patent-Cliff Crosswalk Guide.